Registration - Consultant

Apotex / Apotex / Harry Radomski, Consultant

Registration Information

Client name: Apotex / Apotex
Lobbyist name: Harry Radomski, Consultant
Initial registration start date: 2012-01-12
Registration status: Inactive
Registration Number: 820033-292325

Associated Communications

Total Number of Communication Reports: 2

Monthly communication reports in the last 6 months: 0

Version 2 of 11 (2012-12-05 to 2013-04-18)

Registration versions:

Version 2 of 11 (2012-12-05 to 2013-04-18)

Lobbying Information

Subject Matters

Health
Industry
Intellectual Property
International Trade

Subject Matter Details

Legislative Proposal, Bill or Resolution

Provide input into the Government of Canada's negotiations regarding the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) with respect to pharmaceuticals, counterfeit medicines, border measures and intellectual property.

Regulation

The need for amendments to the Patented Medicines (Notice of Compliance) Regulations of the Patent Act and address operational concerns: bring finality to proceedings under the Regulations, allow generic manufacturers to amend a Notice of Allegation (NOA), and provide meaningful damages and other disincentives to discourage abuse of the Regulations by brand-name companies.

Communication Techniques

Written communication
Oral communication

Government Institutions

Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
Industry Canada

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
150 Signet Drive
Toronto, ON M9L 1T9
Canada

Telephone number: 416-749-9300 Ext. 7366
Fax number: 416-401-3835

Client representative

Jack Kay, President

Parent Company Information

Apotex / Apotex is not a subsidiary of any other parent companies.

Coalition Members Information

Apotex / Apotex is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Apotex / Apotex are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

ACCUCAPS INDUSTRIES LIMITED / ACCUCAPS INDUSTRIES LIMITED
- 2125 AMBASSADOR DRIVE
  WINDSOR, ON N9C 3R5
  Canada
APOPHARMA INC. / APOPHARMA INC.
- 200 BARMAC DRIVE
  Toronto, ON M9L 2Z7
  Canada
APOTEX FERMENTATION INC. / APOTEX FERMENTATION INC.
- 50 SCURFIELD BOULEVARD
  WINNIPEG, MB R3Y 1G4
  Canada
APOTEX INTERNATIONAL INC. / APOTEX INTERNATIONAL INC.
- 200 BARMAC DRIVE
  Toronto, ON M9L 2Z7
  Canada
APOTEX PHARMACHEM INC. / APOTEX PHARMACHEM INC.
- 34 SPALDING DRIVE
  BRANTFORD, ON N9C 3R5
  Canada
STARPLEX SCIENTIFIC
- 50 STEINWAY BOULEVARD
  ETOBICOKE, ON M8W 6Y3
  Canada

Lobbyist Details

Harry Radomski | No public offices held

Business address:
Goodmans LLP 333 Bay Street, Suite 3400
Toronto, ON M5H 2S7
Canada

Telephone number: 416-597-4142
Fax number: 416-979-1234

Consultant Firm and Address

Firm: Goodmans LLP

Address:
333 Bay Street, Suite 3400
Toronto, ON M5H 2S7
Canada

Telephone number: 416-979-2211
Fax number: 416-979-1234

Apotex/Apotex

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Apotex/Apotex	2012-01-12	2017-10-24

Apotex / Apotex

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Harry Radomski, Goodmans LLP (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-2 of 2

Apotex
Consultant: Harry Radomski

Designated Public Office Holders who participated in the communication:
- Paul Halucha, Associate Assistant Deputy Minister | Industry Canada
Subject Matter of the communication: Intellectual Property
Communication date: 2015-09-22
Posted date: 2015-09-28
Communication number: 292325-361624 View associated registration
Apotex
Consultant: Harry Radomski

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Senior Associate Deputy Minister | Industry Canada
- Philip Jennings, Associate Assistant Deputy Minister | Industry Sector | Industry Canada
- John Connell, Associate Assistant Deputy Minister | Strategic Policy Sector | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-01-12
Posted date: 2012-03-02
Communication number: 292325-209947 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Apotex / Apotex / Harry Radomski, Consultant

Registration Information

Associated Communications

Version 2 of 11 (2012-12-05 to 2013-04-18)

Version 2 of 11 (2012-12-05 to 2013-04-18)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Regulation

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address